This trial is testing Juvéderm Vollure, a new injectable filler, to see if it is safe and effective. Subjects will get Juvéderm Vollure on one side of their face and Saline on the other side. They will come back 30 days later and possibly get the Juvéderm Vollure again. They will fill out questionnaires and be assessed for short-term and long-term adverse events.
1 Primary · 5 Secondary · Reporting Duration: Baseline to 90 days after last injection
15 Total Participants · 2 Treatment Groups
Primary Treatment: Allergan Vollure · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: